Eledon Pharmaceuticals (NASDAQ:ELDN) used a presentation at the Leerink Partners Global Healthcare Conference to highlight ...

Great thinkers but not rethinkers limits healthcare leaders; adopting rethinking boosts strategy, engagement, and organizational agility.

In one of the biggest surprises of NASA's OSIRIS-REx mission, its target asteroid, Bennu, turned out to be a jagged, rugged ...

Boise State researchers are part of the team behind the Earth Dynamics Geodetic Explorer, or EDGE, a satellite mission concept aimed at monitoring Earth’s land, ice and coastal regions that NASA ...

Developed in collaboration with independent research firm Verdantix, Quentic's report finds AI rising on EHS agendas with 84% prioritizing adoption and 45% planning investments in reporting automation ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, Inc.'s CMO ...

'Peppa Pig' helps kids learn about kindness, sharing, and inclusion through relatable stories and positive modeling of social skills.

The New York Power Authority has received a waiver from the Federal Aviation Administration allowing expanded use of drone inspections ...

Supreme Court finds police breached the rights of a suspected impaired driver when they opened the door of his vehicle ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Dozens of schools, streets, parks and libraries bear Cesar Chavez's name. In light of sex abuse allegations, officials are moving to strip the labor leader's name from such sites.